CLINICAL TRIALS

Once a Soldier. Forever a Soldier.

From its inception, the U.S. Department of Veterans Affairs has deemed research an essential component to meet its mission: to provide the highest quality of health care possible to those who have served our country. Since 1946, clinical trials have been conducted at the VA that focus on alleviating the conditions prevalent among veterans. The goal of these trials has been to offer new drugs, devices and techniques to veterans to improve their health.  

The principal investigators (PI) affiliated with the CRF are VA physicians who are committed to providing excellent care to their patients. Excellent care starts with an informed patient. Though you may receive many benefits from participating in clinical research as a subject–from gaining access to the latest pharmaceutical developments to the empowering feeling of giving back–there can be some risks, so if you are considering the possibility of participating please take time to evaluate for yourself and with your doctor if doing so is an appropriate option. 

NOW ENROLLING! Open Clinical Trials:

CONDITIONS

STUDY NAME

MORE

CONTACT

Cirrhosis

Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis (SACRED)

Jordan Ricks

502-287-5208

Acute Pancreatitis
Systemic Inflammatory Response Syndrome

A Study of Auxora in Patients with Acute Pancreatitis and Accompanying SIRS (CARPO)

Anne Marie Webb

502-287-5238

Cognitive Impairment
Cardiovascular Disease
Dementia

PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)

Jordan Ricks

502-287-5208

Colorectal Cancer

Evaluation of ctDNA LUNAR-2 Assay in an Average Patient Screening Episode (ECLIPSE)

Denise Zellars

502-287-5222

Colorectal Cancer

Study of ctDNA Guided Therapy in Colorectal Cancer (BESPOKE)

Denise Zellars

502-287-5222

Open Clinical Trials (ENROLLMENT CLOSED):

CONDITIONS

STUDY NAME

MORE

Diabetes Mellitus Type2

Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes (SOUL)

Overweight
Obesity

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT)

COMING SOON! Clinical Trials (NOT YET ENROLLING):

CONDITIONS

STUDY NAME

MORE

Hepatocellular Carcinoma

A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (SURFACE)

Lung Cancer

CliNIcal Utility of ManaGement of Patients witH CT and LDCT Identified Pulmonary Nodules UsinG the Percepta NasAL Swab ClassifiEr (NIGHTINGALE)

Coming Soon

Cardiovascular Disease

Veterans Affairs (VA) Lipid Optimization Reimagined (VALOR-QI) in Veterans with Atherosclerotic Cardiovascular Disease (ASCVD) VA Multisite Project (VALOR)

Coming Soon

CLINICAL RESEARCH FOUNDATION INVESTIGATORS

Gerald Dryden, MD, PhD
Gerald Dryden, MD, PhD
Gastroenterology | Digestive & Liver Health
Sathya Krishnasamy, MD
Sathya Krishnasamy, MD
Endocrinology | Diabetes & Nutrition Care
Forest Arnold, DO, MSc
Forest Arnold, DO, MSc
Infectious Disease
Fred Hendler, MD
Fred Hendler, MD
Oncology | Hematology
Craig McClain, MD
Craig McClain, MD
Gastroenterology | Digestive & Liver Health
Ashutosh Barve, MD, PhD
Ashutosh Barve, MD, PhD
Gastroenterology | Digestive & Liver Health
Mark Burns, MD
Mark Burns, MD
Infectious Disease
Bogdan Moldoveanu, MD
Bogdan Moldoveanu, MD
Pulmonology
Endashaw Omer, MD
Endashaw Omer, MD
Oncology | Gastroenterology | Digestive & Liver Health
Marcus Stoddard, MD
Marcus Stoddard, MD
Cardiovascular Medicine